{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T20:00:05Z","timestamp":1786132805477,"version":"build-2736575974"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","funder":[{"DOI":"10.13039\/501100018609","name":"High-level Hospital Construction Project of Guangdong Provincial People's Hospital","doi-asserted-by":"crossref","award":["2022-PUMCH-B-020"],"award-info":[{"award-number":["2022-PUMCH-B-020"]}],"id":[{"id":"10.13039\/501100018609","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82373158"],"award-info":[{"award-number":["82373158"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["JASN"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:sec>\n                    <jats:title>Key Points<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>Based on the yeast surface display system, we identified three new antigen epitopes of CTLD4, CTLD5, and CTLD6 of phospholipase A2 receptor in membranous nephropathy.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>In the cohort, 82% of patients showed epitopes beyond Ricin and 56% higher risk for nephrotic syndrome per one more epitope (odds ratio, 1.56; 95% confidence interval, 1.28 to 1.91).<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Each additional epitope was associated with 15% lower likelihood in clinical remission in this membranous nephropathy cohort (hazard ratio, 0.85; 95% confidence interval, 0.75 to 0.96).<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The M-type phospholipase A2 receptor (PLA2R) is the main target antigen of idiopathic membranous nephropathy. Four autoantibody-targeted PLA2R epitope domains, including Ricin, CTLD1, CTLD7, and CTLD8, have been identified. Nevertheless, whether the epitope profile is involved in the progression of PLA2R-associated membranous nephropathy remains controversial. Conventional epitope detection techniques have limitations, and new methods are needed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We constructed a yeast surface\u2013displayed PLA2R antigen library by randomly fragmenting the full-length\n                      <jats:italic toggle=\"yes\">PLA2R<\/jats:italic>\n                      gene and expressing them on the yeast surfaces. Fluorescence-activated cell sorting was performed with sera from PLA2R-related membranous nephropathy patients. Antigenic epitopes were identified through sequencing and clustering. To analyze large-scale samples in batches, we used representative monoclonal yeasts of each structural domain, obtained through the sorting procedure for flow analysis. Clinical and laboratory data were collected at baseline and follow-up. Associations between epitope numbers and disease conditions and prognosis were analyzed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The capacity, diversity, and screening specificity of the PLA2R yeast surface display library were validated. Beyond the reported epitopes, CTLD4, CTLD5, and CTLD6 were newly identified as antigenic targets. In our cohort of 389 idiopathic membranous nephropathy patients, 320 (82%) patients showed epitopes beyond the Ricin domain. The positive rates of CTLD1, CTLD5, and CTLD7 were 53%, 45%, and 54%, respectively, while the detection rates of CTLD6, CTLD8, and CTLD4 were lower at 9%, 8%, and 7%, respectively. The multivariable model demonstrated a 56% higher risk for nephrotic syndrome per epitope increment (odds ratio, 1.56; 95% confidence interval, 1.28 to 1.91) after adjustment for gender, age, disease duration, serum creatinine, and anti-PLA2R titer. Multivariable Cox regression demonstrated that each additional epitope was associated with a 15% lower likelihood in clinical remission (hazard ratio, 0.85; 95% confidence interval, 0.75 to 0.96), with subsequent mediation analysis revealing anti-PLA2R titer accounted for 12% of this effect.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Based on the PLA2R yeast surface display system, we identified three new antigen epitopes of PLA2R in membranous nephropathy. The epitope profiles of PLA2R were associated with disease severity and prognosis of membranous nephropathy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1681\/asn.0000000962","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T17:00:40Z","timestamp":1765213240000},"page":"1043-1056","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Mapping of Phospholipase A2 Receptor Epitopes in Idiopathic Membranous Nephropathy and Clinical Relevance of Epitope Profiles"],"prefix":"10.1681","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7740-3313","authenticated-orcid":false,"given":"Yanan","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Nephrology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China"},{"name":"Department of Internal Medicine, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Chen","sequence":"additional","affiliation":[{"name":"Comprehensive AIDS Research Center, Pandemic Research Alliance Unit, Center for Infection Biology, School of Basic Medical Sciences, Tsinghua University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9629-8320","authenticated-orcid":false,"given":"Gang","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1148-0444","authenticated-orcid":false,"given":"Junxian","family":"Hong","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China"},{"name":"Comprehensive AIDS Research Center, Pandemic Research Alliance Unit, Center for Infection Biology, School of Basic Medical Sciences, Tsinghua University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3497-0075","authenticated-orcid":false,"given":"Yangzhong","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4624-0881","authenticated-orcid":false,"given":"Ke","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9753-955X","authenticated-orcid":false,"given":"Sanxi","family":"Ai","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3009-8391","authenticated-orcid":false,"given":"Zhiying","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7771-5934","authenticated-orcid":false,"given":"Peng","family":"Xia","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3000-5518","authenticated-orcid":false,"given":"Haoyuan","family":"Cui","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8040-7913","authenticated-orcid":false,"given":"Ruoke","family":"Wang","sequence":"additional","affiliation":[{"name":"Comprehensive AIDS Research Center, Pandemic Research Alliance Unit, Center for Infection Biology, School of Basic Medical Sciences, Tsinghua University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8418-9661","authenticated-orcid":false,"given":"Xuanling","family":"Shi","sequence":"additional","affiliation":[{"name":"Comprehensive AIDS Research Center, Pandemic Research Alliance Unit, Center for Infection Biology, School of Basic Medical Sciences, Tsinghua University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1080-0830","authenticated-orcid":false,"given":"Xuewang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4931-509X","authenticated-orcid":false,"given":"Linqi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Comprehensive AIDS Research Center, Pandemic Research Alliance Unit, Center for Infection Biology, School of Basic Medical Sciences, Tsinghua University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4729-6673","authenticated-orcid":false,"given":"Yan","family":"Qin","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,12,8]]},"reference":[{"issue":"3","key":"B1-20260526","doi-asserted-by":"crossref","first-page":"609","DOI":"10.2215\/CJN.04160413","article-title":"Glomerular diseases: membranous nephropathy--a modern view","volume":"9","author":"Ponticelli","year":"2014","journal-title":"Clin J Am Soc Nephrol."},{"issue":"9","key":"B2-20260526","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1038\/sj.ki.5000289","article-title":"Renal pathology in idiopathic membranous nephropathy: a new perspective","volume":"69","author":"Troyanov","year":"2006","journal-title":"Kidney Int."},{"key":"B3-20260526","doi-asserted-by":"crossref","first-page":"611317","DOI":"10.3389\/fmed.2020.611317","article-title":"Secondary membranous nephropathy. A narrative review","volume":"7","author":"Moroni","year":"2020","journal-title":"Front Med (Lausanne)."},{"key":"B4-20260526","doi-asserted-by":"crossref","first-page":"1324804","DOI":"10.1155\/2019\/1324804","article-title":"Anti-PLA2R1 antibodies containing sera induce in vitro cytotoxicity mediated by complement activation","volume":"2019","author":"Lateb","year":"2019","journal-title":"J Immunol Res."},{"issue":"5","key":"B5-20260526","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.kint.2019.10.022","article-title":"A novel mouse model of phospholipase A2 receptor 1-associated membranous nephropathy mimics podocyte injury in patients","volume":"97","author":"Meyer-Schwesinger","year":"2020","journal-title":"Kidney Int."},{"issue":"2","key":"B6-20260526","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.kint.2022.09.008","article-title":"Podocyte expression of human phospholipase A2 receptor 1 causes immune-mediated membranous nephropathy in mice","volume":"103","author":"Tomas","year":"2023","journal-title":"Kidney Int."},{"issue":"3","key":"B7-20260526","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1681\/ASN.0000000000000068","article-title":"Pathogenicity of human Anti-PLA 2 R1 antibodies in minipigs: a pilot study","volume":"34","author":"Reinhard","year":"2023","journal-title":"J Am Soc Nephrol."},{"issue":"10","key":"B8-20260526","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1681\/ASN.2014070640","article-title":"Anti-phospholipase A2 receptor antibody titer predicts post-rituximab outcome of membranous nephropathy","volume":"26","author":"Ruggenenti","year":"2015","journal-title":"J Am Soc Nephrol."},{"issue":"6","key":"B9-20260526","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1681\/ASN.2013040430","article-title":"Phospholipase A2 receptor autoantibodies and clinical outcome in patients with primary membranous nephropathy","volume":"25","author":"Hoxha","year":"2014","journal-title":"J Am Soc Nephrol."},{"issue":"8","key":"B10-20260526","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.2215\/CJN.10471013","article-title":"Association of anti-PLA2R antibodies with outcomes after immunosuppressive therapy in idiopathic membranous nephropathy","volume":"9","author":"Bech","year":"2014","journal-title":"Clin J Am Soc Nephrol."},{"issue":"5","key":"B11-20260526","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/ki.2012.486","article-title":"Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy","volume":"83","author":"Kanigicherla","year":"2013","journal-title":"Kidney Int."},{"issue":"2","key":"B12-20260526","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nri724","article-title":"Epitope spreading in immune-mediated diseases: implications for immunotherapy","volume":"2","author":"Vanderlugt","year":"2002","journal-title":"Nat Rev Immunol."},{"issue":"2","key":"B13-20260526","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1681\/ASN.2014050502","article-title":"Identification of a major epitope recognized by PLA2R autoantibodies in primary membranous nephropathy","volume":"26","author":"Fresquet","year":"2015","journal-title":"J Am Soc Nephrol."},{"issue":"2","key":"B14-20260526","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1681\/ASN.2013121315","article-title":"Identification of the immunodominant epitope region in phospholipase A2 receptor-mediating autoantibody binding in idiopathic membranous nephropathy","volume":"26","author":"Kao","year":"2015","journal-title":"J Am Soc Nephrol."},{"issue":"5","key":"B15-20260526","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1681\/ASN.2014111061","article-title":"Epitope spreading of autoantibody response to PLA2R associates with poor prognosis in membranous nephropathy","volume":"27","author":"Seitz-Polski","year":"2016","journal-title":"J Am Soc Nephrol."},{"issue":"1","key":"B16-20260526","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1681\/ASN.2019030273","article-title":"Clinical relevance of domain-specific phospholipase A2 receptor 1 antibody levels in patients with membranous nephropathy","volume":"31","author":"Reinhard","year":"2020","journal-title":"J Am Soc Nephrol."},{"issue":"6","key":"B17-20260526","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nbt0697-553","article-title":"Yeast surface display for screening combinatorial polypeptide libraries","volume":"15","author":"Boder","year":"1997","journal-title":"Nat Biotechnol."},{"issue":"2","key":"B18-20260526","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/nbt785","article-title":"Flow-cytometric isolation of human antibodies from a nonimmune Saccharomyces cerevisiae surface display library","volume":"21","author":"Feldhaus","year":"2003","journal-title":"Nat Biotechnol."},{"issue":"38","key":"B19-20260526","doi-asserted-by":"crossref","first-page":"33511","DOI":"10.1074\/jbc.M111.270553","article-title":"Comprehensive analysis of pathogen-specific antibody response in vivo based on an antigen library displayed on surface of yeast","volume":"286","author":"Zuo","year":"2011","journal-title":"J Biol Chem."},{"issue":"1","key":"B20-20260526","doi-asserted-by":"crossref","first-page":"8855","DOI":"10.1038\/ncomms9855","article-title":"Comprehensive analysis of antibody recognition in convalescent humans from highly pathogenic avian influenza H5N1 infection","volume":"6","author":"Zuo","year":"2015","journal-title":"Nat Commun."},{"issue":"1","key":"B21-20260526","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12977-016-0243-3","article-title":"Spatiotemporal hierarchy in antibody recognition against transmitted HIV-1 envelope glycoprotein during natural infection","volume":"13","author":"Jin","year":"2016","journal-title":"Retrovirology."},{"issue":"12","key":"B22-20260526","doi-asserted-by":"crossref","first-page":"e93042","DOI":"10.1172\/jci.insight.93042","article-title":"Delineating antibody recognition against Zika virus during natural infection","volume":"2","author":"Yu","year":"2017","journal-title":"JCI Insight."},{"issue":"3","key":"B23-20260526","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1074\/jbc.M117.816447","article-title":"Epitope-focused immunogens against the CD4-binding site of HIV-1 envelope protein induce neutralizing antibodies against auto- and heterologous viruses","volume":"293","author":"Wang","year":"2018","journal-title":"J Biol Chem."},{"issue":"5","key":"B24-20260526","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/protein\/gzz035","article-title":"A yeast display immunoprecipitation screen for targeted discovery of antibodies against membrane protein complexes","volume":"32","author":"Lajoie","year":"2019","journal-title":"Protein Eng Des Sel."},{"issue":"10","key":"B25-20260526","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1681\/ASN.2012030242","article-title":"Antiphospholipase A2 receptor antibody titer and subclass in idiopathic membranous nephropathy","volume":"23","author":"Hofstra","year":"2012","journal-title":"J Am Soc Nephrol."},{"issue":"1","key":"B26-20260526","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ymeth.2012.03.014","article-title":"Protein selection using yeast surface display","volume":"60","author":"Gera","year":"2013","journal-title":"Methods."},{"issue":"2","key":"B27-20260526","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2174\/138620708783744516","article-title":"A decade of yeast surface display technology: where are we now?","volume":"11","author":"Pepper","year":"2008","journal-title":"Comb Chem High Throughput Screen."},{"issue":"3","key":"B28-20260526","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s00253-012-4175-0","article-title":"Recent developments in yeast cell surface display toward extended applications in biotechnology","volume":"95","author":"Tanaka","year":"2012","journal-title":"Appl Microbiol Biotechnol."},{"issue":"2","key":"B29-20260526","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.abb.2012.04.022","article-title":"Directed evolution of proteins for increased stability and expression using yeast display","volume":"526","author":"Traxlmayr","year":"2012","journal-title":"Arch Biochem Biophys."},{"issue":"2","key":"B30-20260526","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1681\/ASN.2017070734","article-title":"Phospholipase A2 receptor 1 epitope spreading at baseline predicts reduced likelihood of remission of membranous nephropathy","volume":"29","author":"Seitz-Polski","year":"2018","journal-title":"J Am Soc Nephrol."},{"key":"B31-20260526","doi-asserted-by":"crossref","first-page":"412","DOI":"10.3389\/fmed.2020.00412","article-title":"Personalized medicine for PLA2R1-Related membranous nephropathy: a multicenter randomized control trial","volume":"7","author":"Brglez","year":"2020","journal-title":"Front Med (Lausanne)."},{"issue":"2","key":"B32-20260526","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1515\/cclm-2022-0720","article-title":"Quantitative detection of anti-PLA2R antibodies targeting different epitopes and its clinical application in primary membranous nephropathy","volume":"61","author":"Qin","year":"2023","journal-title":"Clin Chem Lab Med."},{"issue":"5","key":"B33-20260526","doi-asserted-by":"crossref","first-page":"e0302100","DOI":"10.1371\/journal.pone.0302100","article-title":"Predictive value of the domain specific PLA2R antibodies for clinical remission in patients with primary membranous nephropathy: a retrospective study","volume":"19","author":"Zhou","year":"2024","journal-title":"PLoS One."},{"issue":"20","key":"B34-20260526","doi-asserted-by":"crossref","first-page":"11096","DOI":"10.3390\/ijms252011096","article-title":"Epitope spreading in immune-mediated glomerulonephritis: the expanding target","volume":"25","author":"Strizzi","year":"2024","journal-title":"Int J Mol Sci."},{"key":"B35-20260526","doi-asserted-by":"crossref","first-page":"848","DOI":"10.3389\/fimmu.2020.00848","article-title":"C1q A08 is a half-cryptic epitope of anti-C1q A08 antibodies in lupus nephritis and important for the activation of complement classical pathway","volume":"11","author":"Wu","year":"2020","journal-title":"Front Immunol."},{"key":"B36-20260526","doi-asserted-by":"crossref","first-page":"1204777","DOI":"10.3389\/fimmu.2023.1204777","article-title":"Tertiary lymphoid structures as local perpetuators of organ-specific immune injury: implication for lupus nephritis","volume":"14","author":"Wang","year":"2023","journal-title":"Front Immunol."},{"issue":"2","key":"B37-20260526","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/1529-0131(200102)44:2<463::AID-ANR65>3.0.CO;2-9","article-title":"Antineutrophil cytoplasmic antibodies reacting with the pro form of proteinase 3 and disease activity in patients with Wegener's granulomatosis and microscopic polyangiitis","volume":"44","author":"Russell","year":"2001","journal-title":"Arthritis Rheum."},{"issue":"3","key":"B38-20260526","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1365-2249.2011.04372.x","article-title":"Epitope specificity of myeloperoxidase antibodies: identification of candidate human immunodominant epitopes","volume":"164","author":"Bruner","year":"2011","journal-title":"Clin Exp Immunol."}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1681\/ASN.0000000962","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:24:21Z","timestamp":1786130661000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1681\/ASN.0000000962"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,8]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.0000000962","relation":{},"ISSN":["1046-6673","1533-3450"],"issn-type":[{"value":"1046-6673","type":"print"},{"value":"1533-3450","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,8]]},"assertion":[{"value":"2025-04-06","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-01","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}